Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod oromucosal film for oral leukoplakia
ISRCTN96581837Phase 2Not yet recruiting
- Sponsor
- Mucora Therapeutics
- Start
- Jan 2027
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of imiquimod in leukoplakia, sponsored by Mucora Therapeutics. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
imiquimod
03
Conditions
leukoplakia
Beyond the preview
Go deeper on ISRCTN96581837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96581837.